Nutritional Strategies After Muscle Strain Injuries
Skeletal Muscle Strain Injuries and the Connective Tissue: Optimal Nutritional Strategies During Rehabilitation After Acute Muscle Strain Injuries
1 other identifier
interventional
50
1 country
1
Brief Summary
Muscle strain injuries are a particularly frequent type of sports injury in soccer, athletics, badminton/ tennis and cross-fit fitness, thereby affecting a broad range of popular leisure time activities. Depending on severity, sports-active individuals may experience long-term functional impairment and pain. Additionally, individuals having sustained one strain injury have a substantially increased risk of injuring the same muscle again. Strain injuries lead to long-term, potentially permanent, loss of muscle mass, thereby weakening the muscle. Muscle atrophy is likely a major factor in the high re-injury risk. Further, strain injuries are associated with a long-term inflammatory response. In the current study, the investigators seek to study interventions to prevent the loss of muscle mass and elaborate on strategies to address the prolonged inflammation observed at the site of the injured muscle. The primary aim of this study is to investigate the effect of protein supplementation on the reduction of muscle atrophy following a severe muscle strain injury in comparison to a carbohydrate supplement. As a second purpose, this study aims to elaborate on findings of prolonged inflammation intra-/ intermuscular by large-scale protein analysis and the characterization of cells active at the site of injury. The study includes the following hypotheses:
- 1.Protein supplementation administered in combination with a gradually increasing loading regime (rehabilitation with weekly progression in load/ intensity) will be effective in reducing the injury-related loss of muscle mass.
- 2.The environment at the site of injury is not only pro-inflammatory, but contains proteins associated with proteolysis.
- 3.Cells belonging to the group of fibro-adipogenic progenitors will be accumulating intra- and inter-muscularly.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 20, 2019
CompletedFirst Posted
Study publicly available on registry
September 24, 2019
CompletedStudy Start
First participant enrolled
January 16, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 8, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2029
ExpectedJanuary 10, 2024
January 1, 2024
4 years
September 20, 2019
January 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Muscle volume
Change in muscle volume in the injured muscle comparing immediate post injury scan with 3 months post scan plus comparison of change with healthy, contralateral muscle over the same time span.
3 months post injury
Secondary Outcomes (15)
Muscle volume
12 months post injury
Isokinetic muscle strength
3 months post injury
Isokinetic muscle strength
6 months post injury
Isokinetic muscle strength
12 months post injury
Fat infiltration
3 months post injury
- +10 more secondary outcomes
Study Arms (2)
Protein supplementation
EXPERIMENTAL20g protein supplementation twice daily for 3 months
Carbohydrate supplementation
ACTIVE COMPARATOR20g maltodextrin supplementation twice daily for 3 months
Interventions
Daily dose of 40 g whey protein for 3 months
Daily dose of 40 g maltodextrin for 3 months
Progressive rehabilitation following a muscle strain injury for 3 months
Eligibility Criteria
You may qualify if:
- Sports-active men and women
- Acute muscle strain injury in either the calf muscles or the hamstring muscles
- Visible tear at the muscle-connective tissue interface visible on an US scan as a hypo-/ hyperechoic area
You may not qualify if:
- Unwillingness to return to sports
- Claustrophobia
- Daily intake of non-steroidal anti-inflammatory drugs (NSAIDs) within 3 months prior to the strain injury
- Smoking
- Diagnosed or suspected type I or type II diabetes
- Diagnosed or suspected connective tissue and/or rheumatic diseases
- Any observed organ dysfunctions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bispebjerg Hospitallead
- University of Copenhagencollaborator
- University Hospital Bispebjerg and Frederiksbergcollaborator
Study Sites (1)
Institute of Sports Medicine Copenhagen, Bispebjerg Hospital, Nielsine Nielsen Vej 11, Building 8
Copenhagen, 2400, Denmark
Related Publications (1)
Mertz KH, Sorensen HH, Lorentz C, Johansen E, Fredskild NU, Wulff MW, Svensson RB, Kjaer MB, Linden FH, Kjaer M, Bayer ML. Effects of Protein Supplementation During Early Rehabilitation on Muscle Volume and Function After Acute Muscle Strain Injuries: A Randomized Controlled Trial. Scand J Med Sci Sports. 2025 Apr;35(4):e70043. doi: 10.1111/sms.70043.
PMID: 40145631DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Monika L Bayer, PhD
Institute of Sports Medicine, Copenhagen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Researcher
Study Record Dates
First Submitted
September 20, 2019
First Posted
September 24, 2019
Study Start
January 16, 2020
Primary Completion
January 8, 2024
Study Completion (Estimated)
August 1, 2029
Last Updated
January 10, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share
Individual de-identified participant data or other documents such as study protocol will not be shared with any third party. A potential change in the data sharing plan after registration will be acknowledged as a statement in a submitted/ published manuscript. A change in the data sharing statement will furthermore be updated in the registry record.